Unveiling the Hidden Stroke Threat in Patients with Atrial Fibrillation and Primary Hyperparathyroidism

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia with a significant association with ischemic stroke1. Risk assessment tools, such as the CHA2DS2-VASc score, have been instrumental in helping clinicians predict stroke risk in AF patients and guide preventive anticoagulation therapy2. However, while traditional and non-traditional cardiovascular (CV) risk factors have been extensively studied, the influence of non-diabetic endocrine disorders on thrombotic risk in AF remains understudied3, 4.

Source: The American Journal of Cardiology - March 5, 2024 Category: Cardiology Authors: Georges Khattar, Samer Asmar, Elie Bou Sanayeh, Praneeth Keesari, Wissam Rahi, Fouad Sakr, Michel Khoury, Michael Cinelli, Samantha Lee, Mitchell Weinberg, Marcin Kowalski, Valay Parikh Source Type: research